股东批准反向分拆、大量股权增加和深度折扣优先股出售

summarizeSummary

The approval of these proposals indicates the company is taking drastic measures to address its financial situation and maintain its Nasdaq listing. The authorization for a reverse stock split, with a wide ratio range, suggests efforts to boost the per-share price. The increase in authorized common shares to 2 billion, from approximately 24.5 million outstanding, creates substantial room for future dilution. Most critically, the approval to sell Series C Preferred Stock to RQS Capital Limited for $30,000, where each preferred share is exchangeable for 100 common shares, effectively sells 3 million common share equivalents at an extremely low price of $0.01 per share, representing significant dilution at a deep discount to the current market price. This financing structure points to a company in distress, securing capital under highly unfavorable terms. Investors should be aware of the substantial dilution risk and the implications for shareholder value.

check_boxKey Events

• 已获批准的反向股分裂

  股东授权董事会在一年内在不需要进一步股东批准的情况下执行反向股分配， düzenlemier ratio 从一比二到一比一百。 这是基于 2026 年 1 月 2 日和 1 月 13 日分别提交的 PRE 14A 和 DEF 14A 文件的这一批准。

• 授权股本大幅增加

  公司普通股认可股数增加至20亿股，远远超过现有约2450万股，导致未来的股价稀释程度显著。这也遵循了2026年1月13日的DEF 14A提交。

• 深度折扣优先股出售获批准

  股东们批准了将 30,000 股 C 系列优先股出售给 RQS Capital Limited，总价为 30,000 美元。每一股 C 系列优先股可以兑换 100 股普通股，并享有 100 股普通股投票权，实际上是在极低的价格 0.01 美元每股出售 3,000,000 股普通股等值股，表明在当前市场价格的深度折扣下造成了显著的稀释。

• 董事会成员选举与审计师认可

  年度股东大会还包括七名董事的连任以及选举 Bush & Associates CPA 为截至 2026 年 7 月 31 日的财务年度的独立注册会计师事务所。

auto_awesomeAnalysis

The approval of these proposals indicates the company is taking drastic measures to address its financial situation and maintain its Nasdaq listing. The authorization for a reverse stock split, with a wide ratio range, suggests efforts to boost the per-share price. The increase in authorized common shares to 2 billion, from approximately 24.5 million outstanding, creates substantial room for future dilution. Most critically, the approval to sell Series C Preferred Stock to RQS Capital Limited for $30,000, where each preferred share is exchangeable for 100 common shares, effectively sells 3 million common share equivalents at an extremely low price of $0.01 per share, representing significant dilution at a deep discount to the current market price. This financing structure points to a company in distress, securing capital under highly unfavorable terms. Investors should be aware of the substantial dilution risk and the implications for shareholder value.